Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis

Journal of Rheumatology

Volumn 24, Issue 7, 1997, Pages 1403-1409

  De Benedetti, Fabrizio ^a   Pignatti, Patrizia ^a   Gerloni, Valeria ^a   Massa, Margherita ^a   Sartirana, Paola ^a   Caporali, Roberto ^a   Montecucco, Carlo Maurizio ^a   Corti, Angelo ^a   Fantini, Flavio ^a   Martini, Alberto ^a,b  

^a Department of Rheumatology ^*  (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cytokines; Juvenile rheumatiod arthritis; Synovial fluid

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 ANTIBODY; LEUKEMIA INHIBITORY FACTOR; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; BIOASSAY; CHILD; DRUG BLOOD LEVEL; GENETIC HETEROGENEITY; HUMAN; IMMUNOASSAY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SAMPLING; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-11; INTERLEUKIN-6; LYMPHOKINES; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030755904     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
2. Drewlow B, Lovis R, Haag MA, et al: Recombinant human interleukin 1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum 1996;39:257-65.
3. Elliot MJ, Maini RN, Feldman M, et al: Treatment of rheumatoid arthritis with chimaeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
4. Wendling D, Racadof L, Wijdenes J: Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993;20:259-62.
5. Elliot MJ, Maini RN, Feldman M, et al: Randomised double blind comparison of chimaeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;334:1105-10.
6. Brewer EJ Jr, Bass J, Baum J, et al: Current proposed revision of JRA criteria. Arthritis Rheum 1977;20:195-9.
7. Grom AA, Giannini EH, Glass DN: Juvenile rheumatoid arthritis and the trimolecular complex (HLA, T cell receptor, and antigen). Differences from rheumatoid arthritis. Arthritis Rheum 1994;37:601-7.
8. Cassidy JT, Levinson JE, Bass JC, et al: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81.
9. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Corti A, Poiesi C, Merli S, Cassani G: Tumor necrosis factor (TNF) a quantification by ELISA and bioassay: Effects of TNFα-soluble TNF receptor (p55) complex dissociations during assay incubations. J Immunol Meth 1994;177:191-8.
11. Corti A, Bagnasco L, Cassani G: Identification of an epitope of tumor necrosis factor (TNF)-receptor type I (p55) recognized by a TNF-α antagonist monoclonal antibody. Lymphokine Cytokine Res 1994;13:183-90.
12. De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A: Correlation of serum interleukin 6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:1158-63.
13. Burger R, Gramatzki M: Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. J Immunol Meth 1993;158:147-8.
14. Madson KL, Moore YL, Lawrence JM III, Osborn TG: Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-63.
15. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW: A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 1995;38:221-8.
16. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;71:1627-52.
17. Fuhlbrigge RC, Sheehan KC, Schreiber RD, Chaplin DC, Unanue ER: Monoclonal antibodies to murine IL-1α. Production, characterization, and inhibition of membrane-associated IL-1 activity. J Immunol 1988;121:2643-50.
18. Bonnefoy JY, Denoroy MC, Guillot O, Martens CL, Bancherau J: Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1α and secretion of IL-1ß. J Immunol 1989;143:864-9.
19. Zola H, Flego L, Wong YT, Macardle PJ, Kenney JS: Direct demonstration of membrane IL-1α on the surface of circulating B lymphocytes and monocytes. J Immunol 1993;150:1750-62.
20. Kaplanski G, Farnarier C, Kaplanski S, et al: Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994;84:4242-8.
21. De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A: Serum interleukin 6 and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 1992;10:493-8.
22. Lepore L, Pennesi M, Saletta S, Perticarari S, Presani G, Prodan M: Study of IL-2, IL-6, TNFα, IFNγ and ß in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994;12:561-5.
23. Rooney M, David J, Symons J, Di Giovine F, Varsani H, Woo P: Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-60.
24. Mangge H, Kenzian H, Gallistl S, et al: Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20.
25. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble IL-6 receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
26. Eberhard BA, Laxer RM, Andersson U, Silverman ED: Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994;96:260-6.
27. Cazzola M, Ponchio L, De Benedetti F, et al: Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic juvenile rheumatoid arthritis. Blood 1996;87:4824-30.
28. Nietfeld JJ, Wilbrink B, Helle M, et al: Interleukin 1-induced interleukin 6 is required for the inhibition of proteoglycan synthesis by interleukin 1 in human articular cartilage. Arthritis Rheum 1990;33:1695-701.
29. Tamura T, Udagawa N, Takahashi N, et al: Soluble interleukin 6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993;90:11924-8.
30. Poli V, Balena R, Fattori E, et al: lnterleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-96.
31. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y: Interleukin 6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
32. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-54.
33. Girasole G, Passeri G, Jilka L, Manolagas SC: Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-24.
34. Lotz M, Moats T, Villiger PM: Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992;90:888-96.
35. Maini RN, Elliot MJ, Brennan FM, et al: Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995;144:195-223.
36. Elliot MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN: Treatment of systemic juvenile chronic arthritis with monoclonal anti-TNFα. Temporary control of systemic but not articular features of disease (abstr). Arthritis Rheum 1994;(suppl 9)37:S276.
37. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
38. Elliot MJ, Maini RN: New directions for biological therapy in rheumatoid arthritis. Int Arch Allergy Immunol 1994;104:112-25.